ID

24890

Beskrivning

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Nyckelord

Versioner (3)
  1. 2017-08-22 2017-08-22 -
  2. 2017-08-22 2017-08-22 -
  3. 2017-09-04 2017-09-04 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

22 augusti 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

Engelsk

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 Formulär  
RANDOMIZATION AND COHORT ASSIGNMENT
Beskrivning

RANDOMIZATION AND COHORT ASSIGNMENT

Alias
UMLS CUI-1
C0034656
After review of all eligibility criteria is the patient eligible for the study?
Beskrivning

patient eligible for clinical trial

Datatyp

text

Alias
UMLS CUI [1]
C1302261
Randomization Number
Beskrivning

randomization numb

Datatyp

integer

Alias
UMLS CUI [1]
C2986235
Tillbaka till toppen

Similar models

randomization determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
RANDOMIZATION AND COHORT ASSIGNMENT
C0034656 (UMLS CUI-1)
Item
After review of all eligibility criteria is the patient eligible for the study?
text
C1302261 (UMLS CUI [1])
patient eligible for clinical trial
Code List
After review of all eligibility criteria is the patient eligible for the study?
CL Item
Yes - Please telephone the Central Randomization Center to enroll the patient. Record the assigned (1)
CL Item
Randomization Number and check the appropriate box to indicate the assigned Cohort in the (Randomization Number and check the appropriate box to indicate the assigned Cohort in the)
CL Item
section below. (section below.)
CL Item
No - Record the reason for Screen Failure on the "Patient Screening/Enrollment Log." (2)
randomization numb
Item
Randomization Number
integer
C2986235 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial